
Samantha L. Shterengarts
Examiner (ID: 8624, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1623, 4131 |
| Total Applications | 2403 |
| Issued Applications | 1806 |
| Pending Applications | 134 |
| Abandoned Applications | 481 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18657597
[patent_doc_number] => 20230303506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA
[patent_app_type] => utility
[patent_app_number] => 18/087890
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18087890
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/087890 | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia | Dec 22, 2022 | Issued |
Array
(
[id] => 18837710
[patent_doc_number] => 11845773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Trehalose analogues
[patent_app_type] => utility
[patent_app_number] => 18/068852
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 20084
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18068852
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/068852 | Trehalose analogues | Dec 19, 2022 | Issued |
Array
(
[id] => 19784167
[patent_doc_number] => 20250057846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A MUSCARINIC RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA
[patent_app_type] => utility
[patent_app_number] => 18/722220
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18722220
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/722220 | COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A MUSCARINIC RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA | Dec 19, 2022 | Pending |
Array
(
[id] => 18451360
[patent_doc_number] => 20230192638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => POLYPHENOLS DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/082401
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082401
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082401 | POLYPHENOLS DERIVATIVES | Dec 14, 2022 | Abandoned |
Array
(
[id] => 18483558
[patent_doc_number] => 20230210856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/066677
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18066677
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/066677 | METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF | Dec 14, 2022 | Abandoned |
Array
(
[id] => 19043545
[patent_doc_number] => 11932629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => KDM1A inhibitors for the treatment of disease
[patent_app_type] => utility
[patent_app_number] => 18/066667
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39006
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18066667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/066667 | KDM1A inhibitors for the treatment of disease | Dec 14, 2022 | Issued |
Array
(
[id] => 18294692
[patent_doc_number] => 20230104378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => FLUORINE-CONTAINING COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/076613
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 405
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/076613 | FLUORINE-CONTAINING COMPOUND | Dec 6, 2022 | Pending |
Array
(
[id] => 18334332
[patent_doc_number] => 20230126280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/075316
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18075316
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/075316 | Hydantoin containing deoxyuridine triphosphatase inhibitors | Dec 4, 2022 | Issued |
Array
(
[id] => 18365911
[patent_doc_number] => 20230147502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => PHOSPHONATE LINKERS AND THEIR USE TO FACILIATE CELLULAR RETENTION OF COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/061034
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061034
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061034 | Phosphonate linkers and their use to facilitate cellular retention of compounds | Dec 1, 2022 | Issued |
Array
(
[id] => 18468780
[patent_doc_number] => 20230203062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => THERAPEUTIC COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/057742
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 162286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057742
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057742 | Therapeutic compounds and methods of use | Nov 20, 2022 | Issued |
Array
(
[id] => 18265336
[patent_doc_number] => 20230086578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => CRYSTALLINE EPINEPHRINE MALONATE SALT
[patent_app_type] => utility
[patent_app_number] => 17/989859
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/989859 | Crystalline epinephrine malonate salt | Nov 17, 2022 | Issued |
Array
(
[id] => 19754312
[patent_doc_number] => 20250042877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => ORGANIC COMPOUND, ORGANIC DEVICE, LIGHT-EMITTING APPARATUS, AND ELECTRONIC APPLIANCE
[patent_app_type] => utility
[patent_app_number] => 18/710010
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18710010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/710010 | ORGANIC COMPOUND, ORGANIC DEVICE, LIGHT-EMITTING APPARATUS, AND ELECTRONIC APPLIANCE | Nov 17, 2022 | Pending |
Array
(
[id] => 19709220
[patent_doc_number] => 20250019362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => METHOD FOR PRODUCING 2-HETEROARYLPYRIDINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/696194
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18696194
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/696194 | METHOD FOR PRODUCING 2-HETEROARYLPYRIDINE COMPOUND | Nov 15, 2022 | Pending |
Array
(
[id] => 18793848
[patent_doc_number] => 11827599
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-28
[patent_title] => Method of preparing ionic fluids
[patent_app_type] => utility
[patent_app_number] => 17/983873
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5674
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/983873 | Method of preparing ionic fluids | Nov 8, 2022 | Issued |
Array
(
[id] => 18597184
[patent_doc_number] => 20230271977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => EXATECAN DERIVATIVES, LINKER-PAYLOADS, AND CONJUGATES AND THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/053459
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053459
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053459 | Exatecan derivatives, linker-payloads, and conjugates and thereof | Nov 7, 2022 | Issued |
Array
(
[id] => 18308012
[patent_doc_number] => 20230111912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => SALTS OF A PIM KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/981887
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17981887
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/981887 | Salts of a Pim kinase inhibitor | Nov 6, 2022 | Issued |
Array
(
[id] => 19247335
[patent_doc_number] => 20240198320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ZIF-8 ORGANOMETALLIC FRAME CATALYST COMPOSITE, AND CARBON DIOXIDE CONVERSION METHOD USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/552589
[patent_app_country] => US
[patent_app_date] => 2022-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552589
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552589 | ZIF-8 ORGANOMETALLIC FRAME CATALYST COMPOSITE, AND CARBON DIOXIDE CONVERSION METHOD USING SAME | Oct 30, 2022 | Pending |
Array
(
[id] => 19210646
[patent_doc_number] => 11999694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Delivery of therapeutic alkaloid compounds
[patent_app_type] => utility
[patent_app_number] => 17/976150
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 57932
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17976150
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/976150 | Delivery of therapeutic alkaloid compounds | Oct 27, 2022 | Issued |
Array
(
[id] => 20092030
[patent_doc_number] => 20250221966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => RXFP1 AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/700349
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 975
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700349
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700349 | RXFP1 AGONISTS | Oct 27, 2022 | Pending |
Array
(
[id] => 19012954
[patent_doc_number] => 11919869
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => CD73 compounds
[patent_app_type] => utility
[patent_app_number] => 18/050404
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 42172
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050404 | CD73 compounds | Oct 26, 2022 | Issued |